Translational medicine: Science or wishful thinking?

Journal of Translational Medicine

Volumn 6, Issue , 2008, Pages

  Wehling, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; ARTICLE; BIOSTATISTICS; DEVICE; DRUG EFFICACY; DRUG SAFETY; INVESTMENT; MEDICAL RESEARCH; RELIABILITY; TRANSLATIONAL MEDICINE; CLINICAL TRIAL; DRUG SCREENING; EDITORIAL; HUMAN; MEDICINE; METHODOLOGY; SCIENCE; THINKING;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION, PRECLINICAL; HUMANS; MEDICINE; SCIENCE; THINKING;

EID: 47349084016     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-6-31     Document Type: Article

References (7)

1. CenterWatch. Drugs approved by FDA http://www.centerwatch.com/patient/ drugs/druglist.html
2. FDA: Challenge and opportunity on the critical path to new medicines http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.pdf
3. Sonntag KC Implementations of translational medicine J Transl Med 2005, 3:33. 1236966 16131400 10.1186/1479-5876-3-33
4. Littman BH Di Mario L Plebani M Marincola FM What's next in translational medicine? Clin Sci (Lond) 2007, 112:217-27. 17223795
5. Wehling M Translational medicine: Can it really facilitate the transition of research "from bench to bedside"? Eur J Clin Pharmacol 2006, 62:91-5. 10.1007/s00228-005-0060-4 16344921
6. Wehling M Translational Science in Medicine-Implications for the Pharmaceutical Industry Int J Pharm Med 2006, 20:1-8. 10.2165/ 00124363-200620050-00004
7. Marincola FM In support of descriptive studies; relevance to translational research J Transl Med 2007, 5:21. 1871566 17474987 10.1186/ 1479-5876-5-21